Abstract

ObjectivesA family history of colorectal cancer (CRC) is an established risk factor for developing CRC, whilst the impact of family history on prognosis is unclear. The present study assessed the association between family history and prognosis and, based on current evidence, explored whether this association was modified by age at diagnosis.MethodsUsing data from the Swedish Colorectal Cancer Registry (SCRCR) linked with the Multigeneration Register and the National Cancer Register, we identified 31 801 patients with a CRC diagnosed between 2007 and 2016. The SCRCR is a clinically rich database which includes information on the cancer stage, grade, location, treatment, complications and postoperative follow‐up.ResultsWe estimated excess mortality rate ratios (EMRR) for relative survival and hazard ratios (HR) for disease‐free survival with 95% confidence intervals (CIs) using flexible parametric models. We found no association between family history and relative survival (EMRR = 0.96, 95% CIs: 0.89–1.03, P = 0.21) or disease‐free survival (HR = 0.98, 95% CIs: 0.91–1.06, P = 0.64). However, age was found to modify the impact of family history on prognosis. Young patients (<50 at diagnosis) with a positive family history had less advanced (i.e. stages I and II) cancers than those with no family history (OR = 0.71, 95% CI: 0.56–0.89, P = 0.004) and lower excess mortality even after adjusting for cancer stage (EMMR = 0.63, 95% CIs: 0.47–0.84, P = 0.002).ConclusionsOur results suggest that young individuals with a family history of CRC may have greater health awareness, attend opportunistic screening and adopt lifestyle changes, leading to earlier diagnosis and better prognosis.

Highlights

  • Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death in the world [1]

  • We found no association between family history and relative survival (EMRR = 0.96, 95% confidence intervals (CIs): 0.89– 1.03, P = 0.21) or disease-free survival (HR = 0.98, 95% CIs: 0.91–1.06, P = 0.64)

  • Young patients (

Read more

Summary

Introduction

Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death in the world [1]. Survival has been increasing over the years, and prognosis is associated with age at diagnosis, cancer stage, grade as well as treatment in both men and women [2]. Evidence indicates there is a heritable component of CRC, which has been previously estimated to be between 15% and 30% [3, 4] with approximately 5% of patients having highly penetrant, hereditary. There is extensive evidence showing improved survival in patients diagnosed with hereditary nonpolyposis CRC (e.g. Lynch syndrome) due to both surveillance and cancer characteristics [7, 8]. There is mixed evidence for the association between familial risk and survival beyond highly penetrant syndromes.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call